Edulis Therapeutics
Edulis Therapeutics is revolutionizing gastrointestinal medicine with an endoscopic drug delivery system designed to impact over 1 million patients by providing sustained, maintenance-free medication. Their innovative bioresorbable implant offers long-term management, fewer complications, reduced patient costs, and is doctor-friendly. The company aims to create a new mode of drug administration that redefines treatment paradigms and improves patient outcomes across various indications, including inflammatory bowel disease and chronic pain management. Their team brings expertise in engineering, pharmaceuticals, and healthcare management, driven by a passion for improving patient care and making healthcare more accessible and efficient.
Industries
Nr. of Employees
small (1-50)
Products
Therapeutic implant program for Crohn's disease (preclinical)
An implantable, endoscopically delivered drug-eluting device being developed for Crohn's disease; program listed at preclinical stage with a named clinical collaborator.
Therapeutic implant program for inflammatory bowel disease (discovery)
Discovery-stage program to apply implant platform to broader inflammatory bowel disease indications.
Therapeutic implant program for weight management (discovery)
Discovery-stage program exploring application of the implant platform for weight-loss indications.
Endoscopic accessory platform (prototyping / regulatory classification)
Platform endoscopic accessory intended to enable deployment of implants; currently in prototyping with consideration of device classification and pathways (510(k) or PMA).
Therapeutic implant program for Crohn's disease (preclinical)
An implantable, endoscopically delivered drug-eluting device being developed for Crohn's disease; program listed at preclinical stage with a named clinical collaborator.
Therapeutic implant program for inflammatory bowel disease (discovery)
Discovery-stage program to apply implant platform to broader inflammatory bowel disease indications.
Therapeutic implant program for weight management (discovery)
Discovery-stage program exploring application of the implant platform for weight-loss indications.
Endoscopic accessory platform (prototyping / regulatory classification)
Platform endoscopic accessory intended to enable deployment of implants; currently in prototyping with consideration of device classification and pathways (510(k) or PMA).
Services
Research and development collaborations with academic institutions, clinical partners, and funding organizations to advance implant programs and device prototypes.
Research and development collaborations with academic institutions, clinical partners, and funding organizations to advance implant programs and device prototypes.
Expertise Areas
- Gastrointestinal targeted drug delivery
- Controlled-release implantable devices
- Endoscopic device development and prototyping
- Preclinical translational development
Key Technologies
- Bioresorbable polymer matrices
- Sustained-release/controlled-release implants
- Endoscopic implantation techniques
- Endoscopic accessory design and prototyping